MRI REMAINS THE METHOD OF CHOICE IN TESTING DISEASE MODIFYING OSTEOARTHRITIS DRUGS.

T1 of Cartilage with Gd-DTPA(2-) and GdHPDO3A: Implications for dGEMRIC Imaging

VALIDATION OF FOCAL CARTILAGE LESION QUANTIFICATION USING MAGNETIC RESONANCE IMAGING: A COMPARISON TO ARTHROSCOPY AND CONTROLLED LESIONS